The Role of PICALM in Alzheimer’s Disease

[1]  L. Tan,et al.  Cognitive Reserve and Alzheimer’s Disease , 2015, Molecular Neurobiology.

[2]  N. Faux,et al.  An anemia of Alzheimer's disease , 2014, Molecular Psychiatry.

[3]  A. Meyer-Lindenberg,et al.  Genetic interaction of PICALM and APOE is associated with brain atrophy and cognitive impairment in Alzheimer's disease , 2014, Alzheimer's & Dementia.

[4]  J. Hardy,et al.  Apolipoprotein E in Alzheimer's disease: an update. , 2014, Annual review of neuroscience.

[5]  Jorng-Tzong Horng,et al.  Correction: Effects of Statins on Incident Dementia in Patients with Type 2 DM: A Population-Based Retrospective Cohort Study in Taiwan , 2014, PLoS ONE.

[6]  Y. Ke,et al.  Reducing iron in the brain: a novel pharmacologic mechanism of huperzine A in the treatment of Alzheimer's disease , 2014, Neurobiology of Aging.

[7]  Jin-Tai Yu,et al.  Autophagy in aging and neurodegenerative diseases: implications for pathogenesis and therapy , 2014, Neurobiology of Aging.

[8]  M. Guerreiro,et al.  Genetic and biochemical markers in patients with Alzheimer's disease support a concerted systemic iron homeostasis dysregulation , 2014, Neurobiology of Aging.

[9]  L. Tan,et al.  Genetic variation in PICALM and Alzheimer's disease risk in Han Chinese , 2014, Neurobiology of Aging.

[10]  D. Hannequin,et al.  hnRNPA2B1 and hnRNPA1 mutations are rare in patients with “multisystem proteinopathy” and frontotemporal lobar degeneration phenotypes , 2014, Neurobiology of Aging.

[11]  M. Clerici,et al.  How plausible is a link between HSV-1 infection and Alzheimer’s disease? , 2014, Expert review of anti-infective therapy.

[12]  Jorng-Tzong Horng,et al.  Effects of Statins on Incident Dementia in Patients with Type 2 DM: A Population-Based Retrospective Cohort Study in Taiwan , 2014, PloS one.

[13]  H. Soininen,et al.  Evidence of altered phosphatidylcholine metabolism in Alzheimer's disease , 2014, Neurobiology of Aging.

[14]  X. Tong,et al.  Selective benefits of simvastatin in bitransgenic APPSwe,Ind/TGF-β1 mice , 2014, Neurobiology of Aging.

[15]  P. Greengard,et al.  The convergence of endosomal and autophagosomal pathways , 2014, Autophagy.

[16]  E. Calabrese,et al.  Titers of herpes simplex virus type 1 antibodies positively correlate with grey matter volumes in Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.

[17]  L. Ferrucci,et al.  Memory decline shows stronger associations with estimated spatial patterns of amyloid deposition progression than total amyloid burden , 2013, Neurobiology of Aging.

[18]  W. Grant,et al.  Trends in diet and Alzheimer's disease during the nutrition transition in Japan and developing countries. , 2013, Journal of Alzheimer's disease : JAD.

[19]  Timothy J. Hohman,et al.  Epistatic Genetic Effects among Alzheimer’s Candidate Genes , 2013, PloS one.

[20]  Y. An,et al.  Alzheimer's disease risk genes and the age-at-onset phenotype , 2013, Neurobiology of Aging.

[21]  Nick C Fox,et al.  Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease , 2013, Nature Genetics.

[22]  D. Harold,et al.  Evidence that PICALM affects age at onset of Alzheimer's dementia in Down syndrome , 2013, Neurobiology of Aging.

[23]  L. Tan,et al.  Epidemiology and etiology of Alzheimer's disease: from genetic to non-genetic factors. , 2013, Current Alzheimer research.

[24]  Yuan Tian,et al.  Adaptor complex AP2/PICALM, through interaction with LC3, targets Alzheimer's APP-CTF for terminal degradation via autophagy , 2013, Proceedings of the National Academy of Sciences.

[25]  D. Yanagisawa,et al.  Mitochondrial ferritin in neurodegenerative diseases , 2013, Neuroscience Research.

[26]  I. Deary,et al.  Clinical and Subclinical Macrovascular Disease as Predictors of Cognitive Decline in Older Patients With Type 2 Diabetes , 2013, Diabetes Care.

[27]  C. Jack,et al.  Multilocus genetic profiling to empower drug trials and predict brain atrophy☆ , 2013, NeuroImage: Clinical.

[28]  O. Combarros,et al.  Genetic risk score predicting accelerated progression from mild cognitive impairment to Alzheimer’s disease , 2013, Journal of Neural Transmission.

[29]  C. Duyckaerts,et al.  Clathrin adaptor CALM/PICALM is associated with neurofibrillary tangles and is cleaved in Alzheimer’s brains , 2013, Acta Neuropathologica.

[30]  M. Wozniak,et al.  Intravenous immunoglobulin reduces beta amyloid and abnormal tau formation caused by herpes simplex virus type 1 , 2013, Journal of Neuroimmunology.

[31]  Zugen Chen,et al.  PICALM Gene rs3851179 Polymorphism Contributes to Alzheimer’s Disease in an Asian Population , 2013, NeuroMolecular Medicine.

[32]  K. Morgan,et al.  Genetic Variants in Alzheimer's Disease , 2013, Springer New York.

[33]  D. Boudreau,et al.  Statins in the prevention of dementia and Alzheimer's disease: A meta‐analysis of observational studies and an assessment of confounding , 2013, Pharmacoepidemiology and drug safety.

[34]  A. Ruiz,et al.  Exploratory analysis of seven Alzheimer's disease genes: disease progression , 2013, Neurobiology of Aging.

[35]  Zugen Chen,et al.  Lack of association between PICALM rs3851179 polymorphism and Alzheimer's disease in Chinese population and APOEε4-negative subgroup , 2013, Neurobiology of Aging.

[36]  K. Fassbender,et al.  Matrix metalloproteinase-12 contributes to neuroinflammation in the aged brain , 2013, Neurobiology of Aging.

[37]  Benjamin F. J. Verhaaren,et al.  Alzheimer's Disease Genes and Cognition in the Nondemented General Population , 2013, Biological Psychiatry.

[38]  M. Ball,et al.  Intracerebral propagation of Alzheimer’s disease: Strengthening evidence of a herpes simplex virus etiology , 2013, Alzheimer's & Dementia.

[39]  F. Vaida,et al.  Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders , 2013, Journal of NeuroVirology.

[40]  Guangjun Nie,et al.  Mitochondrial ferritin attenuates β-amyloid-induced neurotoxicity: reduction in oxidative damage through the Erk/P38 mitogen-activated protein kinase pathways. , 2013, Antioxidants & redox signaling.

[41]  Shigenobu Kanba,et al.  Association study of susceptibility genes for late-onset Alzheimer’s disease in the Japanese population , 2012, Psychiatric genetics.

[42]  J. Haines,et al.  Identification and Confirmation of an Exonic Splicing Enhancer Variation in Exon 5 of the Alzheimer Disease Associated PICALM Gene , 2012, Annals of human genetics.

[43]  A. Simmons,et al.  Tocopherols and tocotrienols plasma levels are associated with cognitive impairment , 2012, Neurobiology of Aging.

[44]  James T Becker,et al.  Effect of Alzheimer's disease risk genes on trajectories of cognitive function in the Cardiovascular Health Study. , 2012, The American journal of psychiatry.

[45]  D. Wechsler,et al.  The PICALM Protein Plays a Key Role in Iron Homeostasis and Cell Proliferation , 2012, PloS one.

[46]  A. Palamara,et al.  Infectious Agents and Neurodegeneration , 2012, Molecular Neurobiology.

[47]  B. Austen,et al.  Amyloid-β Acts as a Regulator of Neurotransmitter Release Disrupting the Interaction between Synaptophysin and VAMP2 , 2012, PloS one.

[48]  B. Salin,et al.  A yeast model for amyloid-β aggregation exemplifies the role of membrane trafficking and PICALM in cytotoxicity , 2012, Disease Models & Mechanisms.

[49]  Simon Lovestone,et al.  Genetic variants influencing human aging from late-onset Alzheimer's disease (LOAD) genome-wide association studies (GWAS) , 2012, Neurobiology of Aging.

[50]  J. Reisch,et al.  Implication of common and disease specific variants in CLU, CR1, and PICALM , 2012, Neurobiology of Aging.

[51]  K. Lunetta,et al.  Multiple loci influencing hippocampal degeneration identified by genome scan , 2012, Annals of neurology.

[52]  J. Schott.  Using CSF biomarkers to replicate genetic associations in Alzheimer's disease , 2012, Neurobiology of Aging.

[53]  W. Markesbery,et al.  Elevated 4-hydroxyhexenal in Alzheimer's disease (AD) progression , 2012, Neurobiology of Aging.

[54]  D A Bennett,et al.  Genotype patterns at PICALM, CR1, BIN1, CLU, and APOE genes are associated with episodic memory , 2012, Neurology.

[55]  Qingli Xiao,et al.  Role of Phosphatidylinositol Clathrin Assembly Lymphoid-Myeloid Leukemia (PICALM) in Intracellular Amyloid Precursor Protein (APP) Processing and Amyloid Plaque Pathogenesis* , 2012, The Journal of Biological Chemistry.

[56]  I. Zerr,et al.  Alzheimer’s Disease: Genetic Polymorphisms and Rate of Decline , 2012, Dementia and Geriatric Cognitive Disorders.

[57]  S. DeKosky,et al.  Association of CLU and PICALM variants with Alzheimer's disease , 2012, Neurobiology of Aging.

[58]  T. Abe,et al.  The Clathrin Assembly Protein PICALM Is Required for Erythroid Maturation and Transferrin Internalization in Mice , 2012, PloS one.

[59]  You-Qiang Song,et al.  Polymorphisms of CR1, CLU and PICALM confer susceptibility of Alzheimer's disease in a southern Chinese population , 2012, Neurobiology of Aging.

[60]  Kelly L. Williams,et al.  Mutation analysis of the optineurin gene in familial amyotrophic lateral sclerosis , 2012, Neurobiology of Aging.

[61]  J. Preston,et al.  Changes in kinetics of amino acid uptake at the ageing ovine blood–cerebrospinal fluid barrier , 2012, Neurobiology of Aging.

[62]  C. Carter,et al.  Alzheimer's Disease: APP, Gamma Secretase, APOE, CLU, CR1, PICALM, ABCA7, BIN1, CD2AP, CD33, EPHA1, and MS4A2, and Their Relationships with Herpes Simplex, C. Pneumoniae, Other Suspect Pathogens, and the Immune System , 2011, International journal of Alzheimer's disease.

[63]  George N. Papadimitriou,et al.  Genetics of Late-Onset Alzheimer's Disease: Update from the Alzgene Database and Analysis of Shared Pathways , 2011, International journal of Alzheimer's disease.

[64]  A. Palamara,et al.  HSV-1 promotes Ca2+-mediated APP phosphorylation and Aβ accumulation in rat cortical neurons , 2011, Neurobiology of Aging.

[65]  A. Roebroek,et al.  LRP1 mediates bidirectional transcytosis of amyloid-β across the blood-brain barrier , 2011, Neurobiology of Aging.

[66]  Sharon E. Miller,et al.  The Molecular Basis for the Endocytosis of Small R-SNAREs by the Clathrin Adaptor CALM , 2011, Cell.

[67]  Alzheimer's Disease Neuroimaging Initiative,et al.  Genome-wide association with MRI atrophy measures as a quantitative trait locus for Alzheimer's disease , 2011, Molecular Psychiatry.

[68]  H. Soares,et al.  Genome-wide association study identifies multiple novel loci associated with disease progression in subjects with mild cognitive impairment , 2011, Translational Psychiatry.

[69]  Guillén Fernández,et al.  CR1 genotype is associated with entorhinal cortex volume in young healthy adults , 2011, Neurobiology of Aging.

[70]  Rui Liu,et al.  Apolipoprotein E genotypes and the risk of Parkinson disease , 2011, Neurobiology of Aging.

[71]  Eric M Reiman,et al.  Functional Links Between Aβ Toxicity, Endocytic Trafficking, and Alzheimer’s Disease Risk Factors in Yeast , 2011, Science.

[72]  M. Eisenstein.  Genetics: Finding risk factors , 2011, Nature.

[73]  P. Greengard,et al.  A small‐molecule enhancer of autophagy decreases levels of Aβ and APP‐CTF via Atg5‐dependent autophagy pathway , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[74]  K. Morgan,et al.  The three new pathways leading to Alzheimer's disease , 2011, Neuropathology and applied neurobiology.

[75]  H. Haapasalo,et al.  CLU, CR1 and PICALM genes associate with Alzheimer's-related senile plaques , 2011, Alzheimer's Research & Therapy.

[76]  D. G. Clark,et al.  Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease , 2011, Nature Genetics.

[77]  Hilkka Soininen,et al.  Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations , 2011, Neurobiology of Aging.

[78]  L. Christiansen,et al.  Genetic variations in the CLU and PICALM genes are associated with cognitive function in the oldest old , 2011, Neurobiology of Aging.

[79]  Jason J. Corneveaux,et al.  CR1 is associated with amyloid plaque burden and age‐related cognitive decline , 2011, Annals of neurology.

[80]  J. O'Brien,et al.  NOS3 gene rs1799983 polymorphism and incident dementia in elderly stroke survivors , 2011, Neurobiology of Aging.

[81]  Holly Soares,et al.  Meta-Analysis for Genome-Wide Association Study Identifies Multiple Variants at the BIN1 Locus Associated with Late-Onset Alzheimer's Disease , 2011, PloS one.

[82]  A. Fagan,et al.  Fine Mapping of Genetic Variants in BIN1, CLU, CR1 and PICALM for Association with Cerebrospinal Fluid Biomarkers for Alzheimer's Disease , 2011, PloS one.

[83]  H. Lehrach,et al.  The role of clusterin, complement receptor 1, and phosphatidylinositol binding clathrin assembly protein in Alzheimer disease risk and cerebrospinal fluid biomarker levels. , 2011, Archives of general psychiatry.

[84]  E. Wijsman,et al.  Genome-Wide Association of Familial Late-Onset Alzheimer's Disease Replicates BIN1 and CLU and Nominates CUGBP2 in Interaction with APOE , 2011, PLoS genetics.

[85]  L. Tan,et al.  Genetic association of PICALM polymorphisms with Alzheimer's disease in Han Chinese , 2011, Journal of the Neurological Sciences.

[86]  M. Mattson,et al.  CALM, A Clathrin Assembly Protein, Influences Cell Surface GluR2 Abundance , 2011, NeuroMolecular Medicine.

[87]  P. Davies,et al.  Novel synthetic small‐molecule activators of AMPK as enhancers of autophagy and amyloid‐β peptide degradation , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[88]  C. Carter.  Alzheimer's Disease: A Pathogenetic Autoimmune Disorder Caused by Herpes Simplex in a Gene-Dependent Manner , 2010, International journal of Alzheimer's disease.

[89]  K. Lunetta,et al.  Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. , 2010, Archives of neurology.

[90]  L. Lagnado,et al.  Clathrin‐Mediated Endocytosis at the Synaptic Terminal: Bridging the Gap Between Physiology and Molecules , 2010, Traffic.

[91]  C. Carter.  APP, APOE, complement receptor 1, clusterin and PICALM and their involvement in the herpes simplex life cycle , 2010, Neuroscience Letters.

[92]  M. Owen,et al.  Distribution and Expression of Picalm in Alzheimer Disease , 2010, Journal of neuropathology and experimental neurology.

[93]  Jason J. Corneveaux,et al.  Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals. , 2010, Human molecular genetics.

[94]  R. Desikan,et al.  Genetic variation and neuroimaging measures in Alzheimer disease. , 2010, Archives of neurology.

[95]  W. Klein,et al.  A Mouse Model of Amyloid β Oligomers: Their Contribution to Synaptic Alteration, Abnormal Tau Phosphorylation, Glial Activation, and Neuronal Loss In Vivo , 2010, The Journal of Neuroscience.

[96]  Judy H. Cho,et al.  Finding the missing heritability of complex diseases , 2009, Nature.

[97]  Nick C Fox,et al.  Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes , 2009, Nature Genetics.

[98]  L. Traub.  Tickets to ride: selecting cargo for clathrin-regulated internalization , 2009, Nature Reviews Molecular Cell Biology.

[99]  P. Yao,et al.  Clathrin-mediated endocytosis and Alzheimer's disease: An update , 2009, Ageing Research Reviews.

[100]  A. Delacourte,et al.  Calpain Hydrolysis of α- and β2-Adaptins Decreases Clathrin-dependent Endocytosis and May Promote Neurodegeneration* , 2009, Journal of Biological Chemistry.

[101]  D. Avramopoulos.  Genetics of Alzheimer's disease: recent advances , 2009, Genome Medicine.

[102]  M. Mattson,et al.  Clathrin Assembly Protein AP180 and CALM Differentially Control Axogenesis and Dendrite Outgrowth in Embryonic Hippocampal Neurons , 2008, The Journal of Neuroscience.

[103]  Y. Goda,et al.  Activity-dependent coordination of presynaptic release probability and postsynaptic GluR2 abundance at single synapses , 2008, Proceedings of the National Academy of Sciences.

[104]  M. Mattson,et al.  Numb Endocytic Adapter Proteins Regulate the Transport and Processing of the Amyloid Precursor Protein in an Isoform-dependent Manner , 2008, Journal of Biological Chemistry.

[105]  Seth Love,et al.  Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial , 2008, The Lancet.

[106]  Guojun Bu,et al.  Endocytosis Is Required for Synaptic Activity-Dependent Release of Amyloid-β In Vivo , 2008, Neuron.

[107]  M. Mattson,et al.  Evidence for CALM in Directing VAMP2 Trafficking , 2008, Traffic.

[108]  Martin Knapp,et al.  Donepezil for the treatment of agitation in Alzheimer's disease. , 2007, The New England journal of medicine.

[109]  J. Bourquin,et al.  The CALM–AF10 fusion is a rare event in acute megakaryoblastic leukemia , 2007, Leukemia.

[110]  W. Klein,et al.  Aβ Oligomers Induce Neuronal Oxidative Stress through an N-Methyl-D-aspartate Receptor-dependent Mechanism That Is Blocked by the Alzheimer Drug Memantine* , 2007, Journal of Biological Chemistry.

[111]  Reinhard Jahn,et al.  SNAREs — engines for membrane fusion , 2006, Nature Reviews Molecular Cell Biology.

[112]  Felix E Schweizer,et al.  The synaptic vesicle: cycle of exocytosis and endocytosis , 2006, Current Opinion in Neurobiology.

[113]  Gopal Thinakaran,et al.  Amyloidogenic processing of β-amyloid precursor protein in intracellular compartments , 2006, Neurology.

[114]  L. Hinrichsen,et al.  Effect of Clathrin Assembly Lymphoid Myeloid Leukemia Protein Depletion on Clathrin Coat Formation , 2005, Traffic.

[115]  R. Nixon.  Endosome function and dysfunction in Alzheimer's disease and other neurodegenerative diseases , 2005, Neurobiology of Aging.

[116]  M. Mattson,et al.  Heterogeneity of endocytic proteins: distribution of clathrin adaptor proteins in neurons and glia , 2003, Neuroscience.

[117]  J. Coorssen,et al.  Calcium-triggered Membrane Fusion Proceeds Independently of Specific Presynaptic Proteins* , 2003, Journal of Biological Chemistry.

[118]  Mitchell L. Klebig,et al.  Mutations in the clathrin-assembly gene Picalm are responsible for the hematopoietic and iron metabolism abnormalities in fit1 mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[119]  Hyung-Lae Kim,et al.  Cleavage of purified neuronal clathrin assembly protein (CALM) by caspase 3 and calpain , 2001, Experimental & Molecular Medicine.

[120]  D. Selkoe.  Alzheimer's disease: genes, proteins, and therapy. , 2001, Physiological reviews.

[121]  P R Evans,et al.  Simultaneous binding of PtdIns(4,5)P2 and clathrin by AP180 in the nucleation of clathrin lattices on membranes. , 2001, Science.

[122]  S. Bohlander,et al.  Clathrin assembly lymphoid myeloid leukemia (CALM) protein: localization in endocytic-coated pits, interactions with clathrin, and the impact of overexpression on clathrin-mediated traffic. , 1999, Molecular biology of the cell.

[123]  A D Roses,et al.  Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease. , 1998, The New England journal of medicine.

[124]  J. Rowley,et al.  The t(10;11)(p13;q14) in the U937 cell line results in the fusion of the AF10 gene and CALM, encoding a new member of the AP-3 clathrin assembly protein family. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[125]  G. Schellenberg,et al.  Candidate gene for the chromosome 1 familial Alzheimer's disease locus , 1995, Science.

[126]  D. Pollen,et al.  Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease , 1995, Nature.

[127]  A. Roses.  Apolipoprotein E Affects the Rate of Alzheimer Disease Expression: (β-Amyloid Burden Is a Secondary Consequence Dependent on APOE Genotype and Duration of Disease , 1994, Journal of neuropathology and experimental neurology.

[128]  M. Pericak-Vance,et al.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[129]  M. Pericak-Vance,et al.  Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease , 1991, Nature.

[130]  Jin-Tai Yu,et al.  Midlife vascular risk factors and the risk of Alzheimer's disease: a systematic review and meta-analysis. , 2014, Journal of Alzheimer's disease : JAD.

[131]  D. Walsh,et al.  Simvastatin treatment preserves synaptic plasticity in AβPPswe/PS1dE9 mice. , 2014, Journal of Alzheimer's disease : JAD.

[132]  O. Lopez,et al.  Beta-amyloid toxicity modifier genes and the risk of Alzheimer's disease. , 2012, American journal of neurodegenerative disease.

[133]  S. Sorbi,et al.  Implication of a genetic variant at PICALM in Alzheimer’s disease patients and centenarians. , 2011, Journal of Alzheimer's disease : JAD.

[134]  E. Porcellini,et al.  Gene signature in Alzheimer's disease and environmental factors: the virus chronicle. , 2011, Journal of Alzheimer's disease : JAD.

[135]  Y. Liu,et al.  PICALM and CR1 variants are not associated with sporadic Alzheimer's disease in Chinese patients. , 2011, Journal of Alzheimer's disease : JAD.

[136]  L. Shaw,et al.  Use of cerebrospinal fluid biomarkers for diagnosis of incipient Alzheimer disease in patients with mild cognitive impairment. , 2010, Clinical chemistry.

[137]  Nick C Fox,et al.  Letter abstract - Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's Disease , 2009 .

[138]  J. Ashford,et al.  Non-familial Alzheimer's disease is mainly due to genetic factors. , 2002, Journal of Alzheimer's disease : JAD.

[139]  B. Katz.  Neural transmitter release: From quantal secretion to exocytosis and beyond—The Fenn Lecture , 1996, Journal of neurocytology.